The “regular” – meaning the conjugate for meningitis serotypes A,C,W, and Y – are on the vaccine schedule recommended for all children at age 11-12 years for the first dose, and 16 years for the second dose.
Here’s the entire vaccine schedule.
https://www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-child-combined-schedule.pdf
This is the CDC explanation of the meningococcal B vaccine:
Serogroup B meningococcal vaccines (minimum age: 10 years [Bexsero, Trumenba].
Clinical discretion: Adolescents not at increased risk for meningococcal B infection who want MenB vaccine.
MenB vaccines may be given at clinical discretion to adolescents 16–23 years (preferred age 16–18 years) who are not at increased risk.
• Bexsero: 2 doses at least 1 month apart.
• Trumenba: 2 doses at least 6 months apart. If the 2nd dose is given earlier than 6 months, give a 3rd dose at least 4 months after the 2nd.
Special populations and situations: Anatomic or functional asplenia, sickle cell disease, persistent complement component deficiency (including eculizumab use), serogroup B meningococcal disease outbreak
• Bexsero: 2-dose series at least 1 month apart.
• Trumenba: 3-dose series at 0, 1-2, and 6 months.
Note: Bexsero and Trumenba are not interchangeable.
For additional meningococcal vaccination information, see meningococcal MMWR publications at: www.cdc.gov/vaccines/hcp/acip-recs/vaccspecific/mening.html